Sign in
4

Changes in Ownership

Avalo Therapeutics, Inc. Filed Acc 0001628280-23-042493

Options or other derivatives

  • Director acquired 3,334 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Persson Magnus · Director

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2023-12-20 Grant or award : show line 1 in the form Stock Option (Right to Buy) +3,334 3,334 D
Loading xslF345X05/wk-form4_1703192719.xml…